Total Payments
$665,599
2024 Payments
$8,158
Companies
44
Transactions
1,613
Medicare Patients
2,905
Medicare Billing
$284,255
Payment Breakdown by Category
Other$539,240 (81.0%)
Travel$67,419 (10.1%)
Consulting$31,134 (4.7%)
Food & Beverage$27,653 (4.2%)
Education$92.88 (0.0%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $464,624 | 344 | 69.8% |
| Travel and Lodging | $67,419 | 171 | 10.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $58,216 | 17 | 8.7% |
| Consulting Fee | $31,134 | 16 | 4.7% |
| Food and Beverage | $27,653 | 1,046 | 4.2% |
| Honoraria | $16,400 | 9 | 2.5% |
| Education | $92.88 | 9 | 0.0% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $276,667 | 545 | $0 (2023) |
| Novo Nordisk Inc | $197,981 | 298 | $0 (2024) |
| Dexcom, Inc. | $126,396 | 134 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14,989 | 34 | $0 (2022) |
| Novo Nordisk AS | $14,868 | 18 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $13,865 | 53 | $0 (2020) |
| Senseonics, Incorporated | $6,411 | 7 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $5,085 | 25 | $0 (2021) |
| Eli Lilly and Company | $1,239 | 2 | $0 (2019) |
| Insulet Corporation | $1,127 | 70 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,158 | 43 | Dexcom, Inc. ($7,440) |
| 2023 | $30,730 | 71 | Dexcom, Inc. ($29,060) |
| 2022 | $37,946 | 90 | Dexcom, Inc. ($36,885) |
| 2021 | $42,226 | 114 | DEXCOM, INC. ($25,728) |
| 2020 | $59,546 | 152 | Lilly USA, LLC ($42,379) |
| 2019 | $135,310 | 384 | Lilly USA, LLC ($77,733) |
| 2018 | $172,355 | 388 | Lilly USA, LLC ($79,325) |
| 2017 | $179,327 | 371 | Novo Nordisk Inc ($68,986) |
All Payment Transactions
1,613 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Bone Health | ||||||
| 10/04/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $583.63 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Endocrinology | ||||||
| 10/02/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,213.00 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $383.00 | General |
| Category: Endocrinology | ||||||
| 09/14/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $483.90 | General |
| Category: Endocrinology | ||||||
| 09/07/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $102.46 | General |
| Category: Endocrinology | ||||||
| 08/12/2024 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 08/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diabetes Care | ||||||
| 07/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Diabetes Care | ||||||
| 07/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Diabetes Care | ||||||
| 06/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $80.02 | General |
| Category: Automated insulin delivery system | ||||||
| 05/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Diabetes Care | ||||||
| 05/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 779 | 1,050 | $211,974 | $49,645 |
| 2022 | 6 | 613 | 879 | $175,176 | $37,990 |
| 2021 | 8 | 693 | 1,055 | $187,758 | $51,282 |
| 2020 | 13 | 820 | 6,506 | $567,413 | $145,338 |
Total Patients
2,905
Total Services
9,490
Medicare Billing
$284,255
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 386 | $108,532 | $25,939 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 305 | 394 | $68,701 | $17,429 | 25.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 55 | 113 | $14,690 | $2,834 | 19.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,581 | $1,933 | 25.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 108 | 108 | $8,316 | $983.88 | 11.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 14 | $3,794 | $454.05 | 12.0% |
| 72020 | X-ray of spine, 1 view | Office | 2023 | 15 | 15 | $360.00 | $71.64 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 289 | 453 | $92,091 | $19,821 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 158 | $46,980 | $11,827 | 25.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 47 | 112 | $14,560 | $2,873 | 19.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 84 | 87 | $11,032 | $1,621 | 14.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $6,432 | $1,347 | 20.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 53 | 53 | $4,081 | $500.85 | 12.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 275 | 492 | $117,036 | $32,745 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 159 | 208 | $32,488 | $10,029 | 30.9% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 44 | 122 | $15,860 | $3,166 | 20.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 80 | 96 | $7,896 | $2,389 | 30.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $4,485 | $1,522 | 33.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 16 | $4,336 | $644.04 | 14.9% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 62 | 62 | $4,793 | $597.68 | 12.5% |
| 72020 | X-ray of spine, 1 view | Office | 2021 | 36 | 36 | $864.00 | $189.60 | 21.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 59 | 5,280 | $257,286 | $80,626 | 31.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 315 | 651 | $223,683 | $46,590 | 20.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 97 | $25,327 | $4,830 | 19.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 47 | 47 | $5,576 | $2,866 | 51.4% |
About Dr. Gregg Gerety, M.D
Dr. Gregg Gerety, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881691152.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregg Gerety, M.D has received a total of $665,599 in payments from pharmaceutical and medical device companies, with $8,158 received in 2024. These payments were reported across 1,613 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($464,624).
As a Medicare-enrolled provider, Gerety has provided services to 2,905 Medicare beneficiaries, totaling 9,490 services with total Medicare billing of $284,255. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Albany, NY
- Active Since 07/01/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1881691152
Products in Payments
- TRULICITY (Drug) $225,878
- Tresiba (Drug) $111,607
- Ozempic (Drug) $42,920
- Dexcom G6 Transmitter (Medical Supply) $37,125
- DEXCOM G7 GSS (161) (Medical Supply) $36,260
- BAQSIMI (Drug) $31,557
- DEXCOM G6 TRANSMITTER (Device) $25,728
- Xultophy 100/3.6 (Drug) $19,640
- JARDIANCE (Drug) $16,036
- INVOKANA (Drug) $13,777
- Dexcom G5 Mobile CGM System (Device) $9,344
- Dexcom CGM (Device) $9,024
- Victoza (Drug) $9,006
- DEXCOM G6 CGM SYSTEM (Device) $8,490
- RYBELSUS (Drug) $7,504
- Eversense (Device) $6,411
- JANUVIA (Drug) $5,070
- Saxenda (Drug) $1,948
- Omnipod (Device) $1,127
- FARXIGA (Drug) $957.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Albany
Dr. Robert Busch, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4.1M
Endocrinology, Diabetes & Metabolism $4.1M
Dr. Jay Watsky, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $83,103
Endocrinology, Diabetes & Metabolism $83,103
Dr. Mark Fruiterman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $37,168
Endocrinology, Diabetes & Metabolism $37,168
Dr. Michael Walker, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,934
Endocrinology, Diabetes & Metabolism $17,934
Dr. Gary Bakst, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,831
Endocrinology, Diabetes & Metabolism $17,831
Dr. Samer Eldeiry, M.d., Ph.d, M.D., PH.D
Endocrinology, Diabetes & Metabolism — Payments: $9,611
Endocrinology, Diabetes & Metabolism $9,611